Real-world adherence and economic outcomes associated with paliperidone palmitate versus oral atypical antipsychotics in schizophrenia patients with substance-related disorders using Medicaid benefits

Overview of attention for article published in Journal of Comparative Effectiveness Research, August 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

So far, Altmetric has seen 9 X posts from 5 X users, with an upper bound of 3,481 followers.

Study compares efficacy & cost of paliperidone palmitate vs antipsychotics https://t.co/sYTOrDvqkx #openaccess #MentalHealthAwarenessDay

[schizo] Real-world adherence and economic outcomes associated with paliperidone palmitate versus oral atypical… https://t.co/oBzZgTw3Hm

RT @JoWFSG: Real-world adherence and economic outcomes associated with paliperidone palmitate versus oral atypical antipsychotic…https://t.…

RT @JoWFSG: Real-world adherence and economic outcomes associated with paliperidone palmitate versus oral atypical antipsychotic…https://t.…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.